Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
Blokirali ste korisnika/cu @ScripVibhaRavi
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ScripVibhaRavi
-
Prikvačeni tweet
Zydus Cadila explores orphan drug indication for NASH candidate Saroglitazar Mg even as Q3 revenues see 1.8% YoY growth, pharma revenues drop 4%
#earnings#NASH#strategy#marketing@scripanjug@ScripIanHaydockhttps://scrip.pharmaintelligence.informa.com/articles/2020/02/05/zydus-cadila-explores-orphan-drug-indication-for-nash-candidate …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Drug Controller General of India approves 'restricted use' of combination of drugs used widely for controlling HIV infection in public health emergency for treating novel
#coronavirus patients: Official sourcesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lupin impairs intangible assets from Gavis acquisition, says led to exceptional loss of INR 15.8 bn (pretax) in Q3
#earnings#MnA#PharmaceuticalHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Granules India gets USFDA approval for colchicine tablets 0.6 mg, bioequivalent to Takeda's Colcrys. Alkem, Dr. Reddy’s, Mylan, Watson are other players
#Pharmaceutical#marketing#regulatoryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
$MRK's effort to get smaller follows a growing industry trend among big pharmas to focus on select therapeutic areas and high-growth innovative brands. But Merck's decision came as a bit of a surprise; CEO Frazier said it was considered for some time.https://scrip.pharmaintelligence.informa.com/articles/2020/02/05/merck-to-spin-out-a-new-company-following-industrys-downsizing-trend …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Pharma Is Priority As GSK Confirms Split With Consumer http://bit.ly/398w9gM
#PharmaScripHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Japan Pharma Unconcerned About Virus Impact - For Nowhttps://scrip.pharmaintelligence.informa.com/articles/2020/02/04/japan-pharma-unconcerned-about-virus-impact--for-now …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
$GSK splitting into two: 1. biopharma company focused on 'science related to the immune system, use of genetics and new technologies'. 2. leader in consumer healthcare.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Ranitidine Recall Dents GSK India, Which Mulls Plant Salehttps://scrip.pharmaintelligence.informa.com/articles/2020/02/04/ranitidine-recall-dents-gsk-india-which-mulls-plant-sale …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Regeneron latest to join coronavirus research effortshttps://scrip.pharmaintelligence.informa.com/articles/2020/02/05/coronavirus-notebook-regeneron-hhs-to-develop-antibody …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
#coronavirus#wuhanvirus#2019nCoV EU Firms Called In As Coronavirus Cases Soarhttps://pink.pharmaintelligence.informa.com/articles/2020/02/05/eu-firms-called-in-as-coronavirus-cases-soar …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Panacea Biotec transfers pharmaceuticals business in slump sale to wholly-owned subsidiary Panacea Biotec Pharma Ltd
#pharmaceuticals#strategy#businessHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
#coronavirus#wuhanoutbreak#2019nCoV Coronavirus Notebook: China Generic Antiviral Filed For Emergency Approvalhttps://scrip.pharmaintelligence.informa.com/articles/2020/02/03/coronavirus-notebook-china-generic-antiviral-filed-for-emergency-approval …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Cipla Rejigs Executives, New Chief For North America Businesshttps://scrip.pharmaintelligence.informa.com/articles/2020/02/03/cipla-rejigs-executives-new-chief-for-north-america-business …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Takeda Ups Guidance On Mainstay Growth, Cost Disciplinehttps://scrip.pharmaintelligence.informa.com/articles/2020/02/04/takeda-ups-guidance-on-mainstay-growth-cost-discipline …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
WHO FAQs on HFN1: Human cases of H5N1 avian influenza occasional, but difficult to transmit the infection from person to person. When people do become infected, mortality rate about 60%https://twitter.com/ScripVibhaRavi/status/1224566419095871489 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amid the Coronavirus crisis, H5N1 avian (bird) flu rears its head in Hunan, China
#coronavirus#publichealth#diseasesPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GSK offers adjuvant expertise to CEPI, companies developing vaccine for 2019-nCoV
#coronavirus#CoronavirusOutbreak#healthcarehttps://twitter.com/PharmaScrip/status/1224377640385155072 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vibha Ravi proslijedio/la je Tweet
Ranitidine NDMA ( correcting typo) impact/ review ... GSK India will explore sale of Vemgal site ...
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
US FDA approval for first-ever food allergy therapy by Aimmune Therapeutics. What is the controversy though?
#healthcare#Pharmaceutical#regulatoryhttps://twitter.com/PharmaScrip/status/1224287020543102976 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.